Reducing Aspergillus fumigatus Virulence through Targeted Dysregulation of the Conidiation Pathway.


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
04 02 2020
Historique:
entrez: 6 2 2020
pubmed: 6 2 2020
medline: 21 10 2020
Statut: epublish

Résumé

Inhalation of conidia of the opportunistic mold

Identifiants

pubmed: 32019801
pii: mBio.03202-19
doi: 10.1128/mBio.03202-19
pmc: PMC7002347
pii:
doi:

Substances chimiques

BrlA protein, Aspergillus fumigatus 0
Fungal Proteins 0
Transcription Factors 0
Virulence Factors 0
Doxycycline N12000U13O

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI130128
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007519
Pays : United States

Informations de copyright

Copyright © 2020 Stewart et al.

Références

Mol Microbiol. 2011 Feb;79(4):1045-62
pubmed: 21210869
Mol Microbiol. 2010 Aug;77(4):891-911
pubmed: 20545865
J Mol Biol. 1999 Sep 17;292(2):195-202
pubmed: 10493868
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W460-4
pubmed: 17567614
J Leukoc Biol. 2008 Jan;83(1):64-70
pubmed: 17884993
F1000Res. 2015 Dec 30;4:1521
pubmed: 26925227
Eur Respir J. 2011 Mar;37(3):532-40
pubmed: 20595155
Appl Environ Microbiol. 2013 Mar;79(5):1751-4
pubmed: 23275515
mBio. 2016 Apr 05;7(2):e00252-16
pubmed: 27048799
Nat Protoc. 2015 Jun;10(6):845-58
pubmed: 25950237
Mediators Inflamm. 2013;2013:809798
pubmed: 24347836
Mol Syst Biol. 2011 Oct 11;7:539
pubmed: 21988835
PLoS Pathog. 2014 Mar 06;10(3):e1003936
pubmed: 24603878
Cell. 1988 Jul 29;54(3):353-62
pubmed: 3293800
PLoS Pathog. 2015 Oct 22;11(10):e1005187
pubmed: 26492565
Med Mycol. 2001;39 Suppl 1:9-17
pubmed: 11800273
PLoS Pathog. 2011 Nov;7(11):e1002372
pubmed: 22102815
PLoS Pathog. 2013;9(8):e1003575
pubmed: 23990787
Sci Transl Med. 2012 Dec 19;4(165):165rv13
pubmed: 23253612
Methods Mol Biol. 2012;845:119-30
pubmed: 22328371
mSphere. 2019 May 8;4(3):
pubmed: 31068436
Bioinformatics. 2009 Jan 1;25(1):22-9
pubmed: 19008249
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
J Immunol. 2014 Jun 1;192(11):5332-42
pubmed: 24790151
J Microbiol. 2016 Mar;54(3):223-31
pubmed: 26920882
Rev Iberoam Micol. 2010 Oct-Dec;27(4):155-82
pubmed: 20974273
Cold Spring Harb Perspect Med. 2014 Nov 06;5(2):a019786
pubmed: 25377144
Infect Immun. 2010 Jul;78(7):3007-18
pubmed: 20439478
Adv Appl Microbiol. 2015;90:93-107
pubmed: 25596030
FEMS Microbiol Lett. 2002 Apr 23;210(1):61-6
pubmed: 12023078
Nucleic Acids Res. 2015 Jul 1;43(W1):W30-8
pubmed: 25943547
Nucleic Acids Res. 2014 Jan;42(1):97-108
pubmed: 24097433
Eur Respir Rev. 2011 Sep 1;20(121):156-74
pubmed: 21881144
Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):7124-7129
pubmed: 28634301
Bioinformatics. 2016 Oct 1;32(19):3047-8
pubmed: 27312411
Stud Mycol. 2013 Mar 15;74(1):1-29
pubmed: 23450714
Nucleic Acids Res. 2015 Jul 1;43(W1):W389-94
pubmed: 25883141
Clin Microbiol Infect. 2006 Apr;12(4):376-80
pubmed: 16524415
Genome Biol. 2014 Feb 03;15(2):R29
pubmed: 24485249
Cell. 1989 Jun 2;57(5):859-68
pubmed: 2655931
Mol Biol Cell. 2005 Dec;16(12):5866-79
pubmed: 16207816
Eukaryot Cell. 2009 Jan;8(1):104-15
pubmed: 19028996
mBio. 2018 Dec 11;9(6):
pubmed: 30538182
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Structure. 1996 Oct 15;4(10):1171-80
pubmed: 8939742
Chemotherapy. 1975;21 Suppl 1:8-18
pubmed: 1171754
Microbiol Mol Biol Rev. 1998 Mar;62(1):35-54
pubmed: 9529886
PLoS Pathog. 2013;9(11):e1003716
pubmed: 24244155
Infect Immun. 2014 Aug;82(8):3199-205
pubmed: 24842927
Cell Microbiol. 2010 Apr 1;12(4):473-88
pubmed: 19889083
Clin Microbiol Rev. 1999 Apr;12(2):310-50
pubmed: 10194462
Eukaryot Cell. 2006 Oct;5(10):1585-95
pubmed: 17030990
Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7963-8
pubmed: 10859354
Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W362-5
pubmed: 16845026
Clin Microbiol Rev. 2009 Jul;22(3):447-65
pubmed: 19597008
Infect Immun. 2008 Aug;76(8):3632-9
pubmed: 18490465
Nat Methods. 2017 Apr;14(4):417-419
pubmed: 28263959
mSphere. 2018 Mar 14;3(2):
pubmed: 29564395
Acta Naturae. 2017 Apr-Jun;9(2):47-58
pubmed: 28740726
Curr Opin Microbiol. 2005 Aug;8(4):385-92
pubmed: 16019255
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
Eukaryot Cell. 2009 Apr;8(4):573-85
pubmed: 19181872
Eukaryot Cell. 2013 Feb;12(2):311-21
pubmed: 23264642

Auteurs

James I P Stewart (JIP)

Department of Experimental Medicine, McGill University, Glen Site, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
Infectious Diseases and Immunity in Global Health Program, Glen Site, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.

Vinicius M Fava (VM)

Infectious Diseases and Immunity in Global Health Program, Glen Site, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
McGill International TB Centre, Glen Site, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.

Joshua D Kerkaert (JD)

Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.

Adithya S Subramanian (AS)

Program in Molecular Medicine, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Biochemistry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Fabrice N Gravelat (FN)

Infectious Diseases and Immunity in Global Health Program, Glen Site, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.

Melanie Lehoux (M)

Infectious Diseases and Immunity in Global Health Program, Glen Site, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.

P Lynne Howell (PL)

Program in Molecular Medicine, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Biochemistry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Robert A Cramer (RA)

Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.

Donald C Sheppard (DC)

Department of Experimental Medicine, McGill University, Glen Site, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada don.sheppard@mcgill.ca.
Infectious Diseases and Immunity in Global Health Program, Glen Site, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
Departments of Medicine and of Microbiology and Immunology, McGill University, Glen Site, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
McGill Interdisciplinary Initiative in Infection and Immunity, Montreal, Quebec, Canada.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH